Praxis Precision Medicines, Inc. PRAX Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Praxis Precision Medicines, Inc. (PRAX) reported accretion (amortization) of discounts and premiums, investments of $655K in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Praxis Precision Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 46.7% year-over-year, from $1.23M to $655K.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2021 to 2025), Praxis Precision Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 19.8% compound annual growth rate (CAGR), from -$2.09M to $3.59M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This metric captures the non-cash adjustments to the carrying value of investment securities, such as the amortization of premiums or accretion of discounts. It reconciles the difference between the purchase price and the face value of debt instruments held by the company.